BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1516457)

  • 1. Clinical trial methodology in pediatric RTI. Preface.
    Dagan R
    Chemotherapy; 1992; 38 Suppl 2():1. PubMed ID: 1516457
    [No Abstract]   [Full Text] [Related]  

  • 2. Third-generation cephalosporins for upper respiratory tract infections.
    van Niekerk CH
    S Afr Med J; 2002 Oct; 92(10):745-6; author reply 746. PubMed ID: 12432789
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacterial infections of the respiratory tract and of the ENT area. Cephalosporin in general practice is effective].
    Hanke K; Blum SP
    MMW Fortschr Med; 2002 Mar; 144(13):36. PubMed ID: 12001587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cephalosporins in the treatment of children with oncohematologic diseases].
    Nepokul'chitskaia NV; Timakov AM; Kondratchik KL; Makhortykh TZh; Tarasova IS; Erina TA
    Antibiot Khimioter; 1998; 43(4):30-2. PubMed ID: 9606502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
    Ito K; Ito M
    J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
    [No Abstract]   [Full Text] [Related]  

  • 7. Panel discussion on respiratory infections in children.
    Albores JM; Fujii R; Disney FA; Rosenthal IM; Syme J
    Postgrad Med J; 1971 Feb; 47():Suppl:59-63. PubMed ID: 5556193
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of cefatrizine in pediatric field (author's transl)].
    Konno M; Nanbu H; Izumi Y; Isono Y; Nakazawa S
    Jpn J Antibiot; 1977 Oct; 30(10):770-85. PubMed ID: 338938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II].
    Shimada J; Ishihara R; Suzuki Y; Ishii Y; Nakazawa A; Deguchi K
    Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience of cefuzoname in pediatric patients. Fundamental and clinical investigations].
    Kamiya H; Arai S; Kawai K; Ihara T; Sakurai M; Shimizu S; Kodama K; Iwasa T; Inoue M; Kojima M
    Jpn J Antibiot; 1987 Apr; 40(4):867-82. PubMed ID: 3613095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.
    van Dyk JC; Terespolsky SA; Meyer CS; van Niekerk CH; Klugman KP
    Pediatr Infect Dis J; 1997 Jan; 16(1):79-81. PubMed ID: 9002110
    [No Abstract]   [Full Text] [Related]  

  • 13. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of cefuzonam (CZON) with cefmenoxime in chronic respiratory tract infections by the double-blind method].
    Soejima R; Matsushima T; Niki Y; Kawane H; Kawanishi M; Watanabe M; Hino J; Nakagawa Y; Umeki S; Sumi M
    Kansenshogaku Zasshi; 1986 Aug; 60(8):865-84. PubMed ID: 3098871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of cefuzonam in children].
    Mochizuki Y; Ohkubo H; Yoshida A; Mayumi M; Mikawa H
    Jpn J Antibiot; 1987 Feb; 40(2):397-404. PubMed ID: 3599388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a clinical trial of the use of a methoxyamine (cefuroxime) in respiratory tract infections in children].
    Castello D; Sacchetti L; Brero P; Poncini L
    Minerva Pediatr; 1981 Sep; 33(17):881-6. PubMed ID: 7031458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of Cephalosporins in childhood].
    Weippl G
    Wien Med Wochenschr Suppl; 1975; 27():23-6. PubMed ID: 1064251
    [No Abstract]   [Full Text] [Related]  

  • 19. [A clinical observation of cefuroxime in pediatric field (author's transl)].
    Ohnuma K; Asuka N; Aoyama R; Nagata K
    Jpn J Antibiot; 1979 Nov; 32(11):1117-21. PubMed ID: 41955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of unlabeled French antibiotic guidelines on antibiotic prescriptions for acute respiratory tract infections in 7 Pediatric Emergency Departments, 2009-2012.
    Angoulvant F; Pereira M; Perreaux F; Soussan V; Pham LL; Trieu TV; Cojocaru B; Guedj R; Cohen R; Alberti C; Gajdos V
    Pediatr Infect Dis J; 2014 Mar; 33(3):330-3. PubMed ID: 24168976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.